Yes, Merck just added last month recruiting center
Post# of 148190
(Total Views: 572)
Posted On: 09/15/2019 12:16:11 AM
Yes, Merck just added last month recruiting centers in their MSS trial with Vicriviroc + Keytruda. I’m sure they have seen great data also, and know what is coming. Vicriviroc failed with HIV in both unmet need in phase 3 and naive population phase 2, both failed efficacy and with 15% discontinued due to adverse effects and 5% develop resistance to Vicriviroc during the trials... not a good choice for cancer either imo.
https://clinicaltrials.gov/ct2/show/NCT03631407
https://clinicaltrials.gov/ct2/show/NCT03631407
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼